NUMINUS WELLNESS INC (NUMI.CA) Stock Fundamental Analysis

Canada • Toronto Stock Exchange • TSX:NUMI • CA67054W1032

0.05 CAD
+0.02 (+42.86%)
Last: Jan 29, 2025, 07:00 PM
Fundamental Rating

3

Overall NUMI gets a fundamental rating of 3 out of 10. We evaluated NUMI against 33 industry peers in the Pharmaceuticals industry. NUMI has a bad profitability rating. Also its financial health evaluation is rather negative. NUMI is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NUMI has reported negative net income.
  • In the past year NUMI has reported a negative cash flow from operations.
  • In the past 5 years NUMI always reported negative net income.
  • NUMI had a negative operating cash flow in each of the past 5 years.
NUMI.CA Yearly Net Income VS EBIT VS OCF VS FCFNUMI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

  • With a Return On Assets value of -213.24%, NUMI is not doing good in the industry: 90.91% of the companies in the same industry are doing better.
  • NUMI's Return On Equity of -644.74% is on the low side compared to the rest of the industry. NUMI is outperformed by 81.82% of its industry peers.
Industry RankSector Rank
ROA -213.24%
ROE -644.74%
ROIC N/A
ROA(3y)-79.64%
ROA(5y)-255.28%
ROE(3y)-118.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NUMI.CA Yearly ROA, ROE, ROICNUMI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K

1.3 Margins

  • NUMI's Gross Margin of 32.02% is in line compared to the rest of the industry. NUMI outperforms 45.45% of its industry peers.
  • In the last couple of years the Gross Margin of NUMI has grown nicely.
  • The Profit Margin and Operating Margin are not available for NUMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 32.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y52.27%
GM growth 5YN/A
NUMI.CA Yearly Profit, Operating, Gross MarginsNUMI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • NUMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NUMI has been increased compared to 1 year ago.
  • Compared to 1 year ago, NUMI has a worse debt to assets ratio.
NUMI.CA Yearly Shares OutstandingNUMI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
NUMI.CA Yearly Total Debt VS Total AssetsNUMI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

  • NUMI has an Altman-Z score of -13.73. This is a bad value and indicates that NUMI is not financially healthy and even has some risk of bankruptcy.
  • NUMI's Altman-Z score of -13.73 is on the low side compared to the rest of the industry. NUMI is outperformed by 81.82% of its industry peers.
  • A Debt/Equity ratio of 0.95 indicates that NUMI is somewhat dependend on debt financing.
  • NUMI has a Debt to Equity ratio of 0.95. This is in the lower half of the industry: NUMI underperforms 78.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Altman-Z -13.73
ROIC/WACCN/A
WACC8.99%
NUMI.CA Yearly LT Debt VS Equity VS FCFNUMI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M 60M

2.3 Liquidity

  • NUMI has a Current Ratio of 1.40. This is a normal value and indicates that NUMI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.40, NUMI perfoms like the industry average, outperforming 51.52% of the companies in the same industry.
  • A Quick Ratio of 1.40 indicates that NUMI should not have too much problems paying its short term obligations.
  • The Quick ratio of NUMI (1.40) is better than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 1.4
NUMI.CA Yearly Current Assets VS Current LiabilitesNUMI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. Growth

3.1 Past

  • NUMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.67%, which is quite impressive.
  • Looking at the last year, NUMI shows a very strong growth in Revenue. The Revenue has grown by 22.69%.
  • The Revenue has been growing by 197.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)37.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.87%
Revenue 1Y (TTM)22.69%
Revenue growth 3Y197.54%
Revenue growth 5YN/A
Sales Q2Q%-27.88%

3.2 Future

  • Based on estimates for the next years, NUMI will show a very strong growth in Earnings Per Share. The EPS will grow by 29.53% on average per year.
  • The Revenue is expected to grow by 22.63% on average over the next years. This is a very strong growth
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y25.99%
EPS Next 5Y29.53%
Revenue Next Year-18.04%
Revenue Next 2Y-0.45%
Revenue Next 3Y11.96%
Revenue Next 5Y22.63%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NUMI.CA Yearly Revenue VS EstimatesNUMI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M
NUMI.CA Yearly EPS VS EstimatesNUMI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2027 2028 2029 2030 0 0.1 -0.1 0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • NUMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NUMI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUMI.CA Price Earnings VS Forward Price EarningsNUMI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUMI.CA Per share dataNUMI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1

4.3 Compensation for Growth

  • NUMI's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.44%
EPS Next 3Y25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for NUMI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NUMINUS WELLNESS INC

TSX:NUMI (1/29/2025, 7:00:00 PM)

0.05

+0.02 (+42.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-13
Earnings (Next)N/A
Inst Owners2.66%
Inst Owner ChangeN/A
Ins Owners3.55%
Ins Owner ChangeN/A
Market Cap16.12M
Revenue(TTM)26.05M
Net Income(TTM)-29.86M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.62
P/FCF N/A
P/OCF N/A
P/B 3.48
P/tB 3.48
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.08
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -213.24%
ROE -644.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 32.02%
FCFM N/A
ROA(3y)-79.64%
ROA(5y)-255.28%
ROE(3y)-118.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y52.27%
GM growth 5YN/A
F-Score2
Asset Turnover1.86
Health
Industry RankSector Rank
Debt/Equity 0.95
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.51%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 1.4
Altman-Z -13.73
F-Score2
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)61.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)21.09%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%35.87%
EPS Next Y58.33%
EPS Next 2Y38.44%
EPS Next 3Y25.99%
EPS Next 5Y29.53%
Revenue 1Y (TTM)22.69%
Revenue growth 3Y197.54%
Revenue growth 5YN/A
Sales Q2Q%-27.88%
Revenue Next Year-18.04%
Revenue Next 2Y-0.45%
Revenue Next 3Y11.96%
Revenue Next 5Y22.63%
EBIT growth 1Y24.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year52.23%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y34.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.26%
OCF growth 3YN/A
OCF growth 5YN/A

NUMINUS WELLNESS INC / NUMI.CA FAQ

What is the ChartMill fundamental rating of NUMINUS WELLNESS INC (NUMI.CA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NUMI.CA.


What is the valuation status of NUMINUS WELLNESS INC (NUMI.CA) stock?

ChartMill assigns a valuation rating of 1 / 10 to NUMINUS WELLNESS INC (NUMI.CA). This can be considered as Overvalued.


Can you provide the profitability details for NUMINUS WELLNESS INC?

NUMINUS WELLNESS INC (NUMI.CA) has a profitability rating of 1 / 10.